Finance

Lists
PHAR:NASDAQ
Pharming Group NV - ADR
12,62 USD
-4,21%
(-0,56) 1D
24-июл., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAR...
Open
12,79 USD
High
12,96 USD
Low
12,57 USD
Mkt. cap
800,47 млн
Avg. vol.
5,80 миң
Volume
0,00
52-wk high
21,30 USD
52-wk low
9,28 USD
Beta
-0,03
Shares outstanding
70,78 млн
No. of employees
407
Open
12,79 USD
High
12,96 USD
Low
12,57 USD
Mkt. cap
800,47 млн
Avg. vol.
5,80 миң
Volume
0,00
52-wk high
21,30 USD
52-wk low
9,28 USD
Beta
-0,03
Shares outstanding
70,78 млн
No. of employees
407
News stories
From sources across the web
About Pharming Group NV - ADR
CEO-
Employees407
Founded1988
Headquarters-
Sector-
Websitepharming.com
Analyst ratings
Based on 3 analysts giving stock ratings to PHAR in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PHAR in the last 3 months.
Highest
Current 12,62 USD
40,00 USD (+217,08%)
Average
38,00 USD (+201,23%)
Lowest
37,00 USD (+193,30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
37,00 USD
+193,3%
07/06/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
37,00 USD
+193,3%
06/22/2026
Jeff Jones
Oppenheimer
Buy
Maintained
40,00 USD
+217,1%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
93,22 млн
97,29 млн
106,53 млн
72,45 млн
Cost of goods sold
8,97 млн
7,07 млн
21,13 млн
6,64 млн
Cost of revenue
8,97 млн
7,07 млн
21,13 млн
6,64 млн
Research and development expenses
25,80 млн
21,28 млн
32,05 млн
25,56 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57,25 млн
43,08 млн
50,67 млн
45,53 млн
Operating expense
81,20 млн
64,29 млн
82,37 млн
70,71 млн
Total operating expenses
90,17 млн
71,36 млн
103,50 млн
77,36 млн
Operating income
3,05 млн
25,92 млн
3,03 млн
-4,91 млн
Other non operating income
-738,00 миң
1,88 млн
403,00 миң
-
EBT including unusual items
7,08 млн
12,76 млн
4,80 млн
-4,75 млн
EBT excluding unusual items
-721,00 миң
22,86 млн
1,61 млн
-4,75 млн
Income tax expense
2,53 млн
5,21 млн
-528,00 миң
459,00 миң
Effective tax rate
35,73%
40,83%
-11,00%
-9,65%
Other operating expenses
-1,85 млн
-71,00 миң
-348,00 миң
-377,00 миң
Net income
4,69 млн
7,55 млн
5,33 млн
-5,21 млн
Net profit margin
5,04%
7,76%
5,00%
-7,20%
Earnings per share
0,01
0,01
0,01
-0,07
Interest and investment income
1,26 млн
-
4,50 млн
3,24 млн
Interest expense
-4,00 миң
-9,21 млн
-
-2,70 млн
Net interest expenses
1,26 млн
-9,21 млн
4,50 млн
542,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
4,28 млн
30,12 млн
6,24 млн
-1,80 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer